a leading provider of land solutions to the bioscience community, announced today the promotion of eight officers across the Company’s fully integrated platform. The Cambridge, Massachusetts and San Diego , California-based professionals have a combined total of quite 14 decades of experience in their respective commercial land disciplines, including deep expertise in bioscience land , and a complete of 56 years with BioMed Realty.

“The promotions are well-deserved, and my colleagues have consistently demonstrated their expertise, leadership and dedication in serving the unique needs of the growing bioscience and technology communities,” said Tim Schoen, President and CEO of BioMed Realty. “Each of them exemplifies our core value of going above and beyond to determine and strengthen relationships with our clients, our community and therefore the broader industry.”

BioMed experienced significant growth in 2019 because the Company continued to supply purpose-built lab and office space within the vital bioscience and technology hubs of San Diego , the San Francisco Bay Area, Seattle, Boston, New York, and therefore the uk . Those listed below are key to the Company’s success and plans for sustained growth.

Kevin Simonsen has been promoted to Executive Vice President, General Counsel and Secretary after most recently serving as the Company’s Senior Vice President, General Counsel and Secretary. He has spent 14 years with BioMed and led corporate legal and risk management teams since 2016. Prior to joining BioMed, Mr. Simonsen served as an attorney at Latham & Watkins LLP based in San Diego . With his promotion, Mr. Simonsen joins the chief Management Committee of the corporate .
Marie Lewis has been promoted to Senior Vice President, Legal and Assistant Secretary after serving as the Company’s Vice President, Legal and Assistant Secretary. Since joining BioMed in 2013, Ms. Lewis has made significant contributions across variety of leasing, acquisition, disposition and financing transactions. Prior to BioMed, Ms. Lewis was an attorney at Gibson Dunn & Crutcher in Los Angeles, and then the managing attorney of real estate transactions at Sempra Energy (NYSE: SRE).
David Hsiao has been elevated to vice chairman , Chief Information Officer after serving as vice chairman , Information Technology. Mr. Hsiao joined BioMed in 2006 and has held information technology positions where he was responsible for the strategic development of business processes, system infrastructure design, and network and cyber security.
Colleen O’Connor becomes vice chairman , Leasing, East Coast and UK markets after serving as Senior Director. Ms. O’Connor’s expanded role now encompasses the management of 4.8 million SF on two continents. Ms. O’Connor joined BioMed in 2014 after spending several years in various finance and accounting roles, last at Fidelity Investments.
Ken Kuras is now vice chairman , Senior Controller of Development after serving as Senior Director, Accounting since 2016, and Director of Asset Management since 2013. Mr. Kuras has held several public accounting positions focused ashore clients since starting his career at KPMG, followed by eight years at Corky McMillin Companies within the role of Vice President, Controller of Homebuilding.
John Moshy is now vice chairman , Development after serving as Senior Director, Development. Mr. Moshy joined BioMed in 2008 and has held several positions overseeing development and construction-related activities within the Seattle and San Diego markets with attention on entitlements, design and project management.
Carlye Murphy becomes vice chairman , Legal after serving as Managing Attorney, Legal. Based in Cambridge-Boston, Ms. Murphy joined BioMed in 2014 from Ropes & Gray LLP, having focused her career on commercial land transactions since 2005.
Kevin Tremblay becomes Vice President, San Diego Market Lead after serving as Senior Director and will continue to oversee leasing transactions for BioMed’s 3.0 million SF San Diego portfolio. Mr. Tremblay joined BioMed in 2013 after an in depth career as a billboard land professional within the San Diego market.
About BioMed Realty

Founded in 2004, and a Blackstone portfolio company since 2016, BioMed Realty owns, operates and develops high-quality bioscience land comprising 13.6 million square feet, including 2.6 million square feet of sophistication A properties in active development to satisfy the growing demand of the bioscience industry. BioMed Realty’s portfolio is found within the leading innovation markets throughout the us and uk , led by Boston-Cambridge, San Francisco, San Diego, Seattle, ny and Cambridge, U.K. With over 200 tenant partners, BioMed Realty provides land solutions for global enterprises, established biotechnology and innovation companies, leading universities and premier research institutions.